Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the history. The operating-status notice and the previous revision entry, v3.4.1, were removed from the page.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and the NIH Clinical Center's operating status. Updated the record to Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.5%

- Check48 days agoChange DetectedThe history page now includes a glossary display option, color-coded diffs showing additions in green and deletions in red, and visible revision notes (e.g., Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check84 days agoChange DetectedIn the page footer, Revision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check106 days agoChange DetectedThe page history shows a new revision, v3.3.2, replacing the prior v3.3.1, indicating a metadata update rather than a change to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.